JP2025060941A5 - - Google Patents
Info
- Publication number
- JP2025060941A5 JP2025060941A5 JP2024231707A JP2024231707A JP2025060941A5 JP 2025060941 A5 JP2025060941 A5 JP 2025060941A5 JP 2024231707 A JP2024231707 A JP 2024231707A JP 2024231707 A JP2024231707 A JP 2024231707A JP 2025060941 A5 JP2025060941 A5 JP 2025060941A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- cdr2
- cdr1
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962843407P | 2019-05-04 | 2019-05-04 | |
| US62/843,407 | 2019-05-04 | ||
| PCT/US2020/030968 WO2020227071A1 (en) | 2019-05-04 | 2020-05-01 | Cd123-binding polypeptides and uses thereof |
| JP2021564745A JP2022532868A (ja) | 2019-05-04 | 2020-05-01 | Ｃｄ１２３結合性ポリペプチド及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564745A Division JP2022532868A (ja) | 2019-05-04 | 2020-05-01 | Ｃｄ１２３結合性ポリペプチド及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025060941A JP2025060941A (ja) | 2025-04-10 |
| JP2025060941A5 true JP2025060941A5 (enExample) | 2025-10-24 |
Family
ID=70740820
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564745A Pending JP2022532868A (ja) | 2019-05-04 | 2020-05-01 | Ｃｄ１２３結合性ポリペプチド及びその使用 |
| JP2024231707A Pending JP2025060941A (ja) | 2019-05-04 | 2024-12-27 | Ｃｄ１２３結合性ポリペプチド及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564745A Pending JP2022532868A (ja) | 2019-05-04 | 2020-05-01 | Ｃｄ１２３結合性ポリペプチド及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11434297B2 (enExample) |
| EP (1) | EP3966242A1 (enExample) |
| JP (2) | JP2022532868A (enExample) |
| CN (2) | CN121021694A (enExample) |
| AU (1) | AU2020269268A1 (enExample) |
| CA (1) | CA3139061A1 (enExample) |
| WO (1) | WO2020227071A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7013753B2 (ja) * | 2017-09-15 | 2022-02-01 | 株式会社三洋物産 | 遊技機 |
| JP7013754B2 (ja) * | 2017-09-15 | 2022-02-01 | 株式会社三洋物産 | 遊技機 |
| JP6879413B2 (ja) * | 2020-06-24 | 2021-06-02 | 株式会社三洋物産 | 遊技機 |
| JP2020151570A (ja) * | 2020-06-24 | 2020-09-24 | 株式会社三洋物産 | 遊技機 |
| WO2022099175A1 (en) * | 2020-11-09 | 2022-05-12 | 2Seventy Bio, Inc. | Cd33 targeted immunotherapies |
| US20240076392A1 (en) * | 2021-02-17 | 2024-03-07 | Igm Biosciences, Inc. | Anti-cd123 binding molecules and uses thereof |
| CA3209454A1 (en) * | 2021-02-26 | 2022-09-01 | Robertus Cornelis ROOVERS | Antibodies that bind cd123 and gamma-delta t cell receptors |
| JP2021079226A (ja) * | 2021-03-01 | 2021-05-27 | 株式会社三洋物産 | 遊技機 |
| JP2021087836A (ja) * | 2021-03-01 | 2021-06-10 | 株式会社三洋物産 | 遊技機 |
| JP2021087833A (ja) * | 2021-03-01 | 2021-06-10 | 株式会社三洋物産 | 遊技機 |
| JP2021079225A (ja) * | 2021-03-01 | 2021-05-27 | 株式会社三洋物産 | 遊技機 |
| AU2022310862A1 (en) | 2021-07-14 | 2024-02-01 | Regeneron Pharmaceuticals, Inc. | Engineered t cell receptors fused to binding domains from antibodies |
| AU2023248532A1 (en) | 2022-04-08 | 2024-11-21 | Regeneron Pharmaceuticals, Inc. | Multipartite receptor and signaling complexes |
| JP7556434B2 (ja) * | 2022-08-22 | 2024-09-26 | 株式会社三洋物産 | 遊技機 |
| JP7556433B2 (ja) * | 2022-08-22 | 2024-09-26 | 株式会社三洋物産 | 遊技機 |
| JP7556432B2 (ja) * | 2022-08-22 | 2024-09-26 | 株式会社三洋物産 | 遊技機 |
| CN115724972B (zh) * | 2022-09-06 | 2024-08-20 | 河北森朗生物科技有限公司 | 抗cd123的纳米抗体、嵌合抗原受体及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| EP0940468A1 (en) | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Humanized antibody variable domain |
| BR9813365A (pt) | 1997-12-05 | 2004-06-15 | Scripps Research Inst | Método para produção e humanização de um anticorpo monoclonal de rato |
| US7217797B2 (en) | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| WO2005040395A1 (en) | 2003-10-22 | 2005-05-06 | Keck Graduate Institute | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| MXPA06011199A (es) | 2004-03-31 | 2007-04-16 | Genentech Inc | Anticuerpos anti-tgf-beta humanizados. |
| NZ604510A (en) | 2010-08-17 | 2013-10-25 | Csl Ltd | Dilutable biocidal compositions and methods of use |
| US10196444B2 (en) | 2013-07-29 | 2019-02-05 | Bluebird Bio, Inc. | Multipartite signaling proteins and uses thereof |
| CN105814082A (zh) * | 2013-09-26 | 2016-07-27 | 埃博灵克斯股份有限公司 | 双特异性纳米抗体 |
| AU2015305531B2 (en) | 2014-08-19 | 2021-05-20 | Novartis Ag | Anti-CD123 chimeric antigen receptor (CAR) for use in cancer treatment |
| JP7001474B2 (ja) | 2015-01-21 | 2022-01-19 | インヒブルクス，インコーポレイティド | 非免疫原性単一ドメイン抗体 |
| TW201709932A (zh) * | 2015-06-12 | 2017-03-16 | 西雅圖遺傳學公司 | Ｃｄ１２３抗體及其共軛物 |
| EP3341410B1 (en) | 2015-08-24 | 2021-06-02 | Cellectis | Chimeric antigen receptors with integrated controllable functions |
| AR106949A1 (es) | 2015-12-04 | 2018-03-07 | Boehringer Ingelheim Int | Polipéptidos biparatópicos que antagonizan la señalización wnt en células tumorales |
| ES2910668T3 (es) * | 2015-12-11 | 2022-05-13 | Leadartis S L | Constructos de fusión de cadena sencilla que comprenden fragmentos de anticuerpos multiméricos fusionados con dominios de trimerización de colágeno |
| JP7224289B2 (ja) * | 2016-09-21 | 2023-02-17 | アプティーボ リサーチ アンド デベロップメント エルエルシー | Ｃｄ１２３結合タンパク質並びに関連する組成物及び方法 |
| CN110177809B (zh) * | 2016-11-16 | 2023-11-03 | 埃博灵克斯股份有限公司 | 能够结合CD123和TCRα/β的T细胞募集多肽 |
| AU2017366739B2 (en) | 2016-12-02 | 2023-11-23 | Angeles Therapeutics, Inc. | Synthetic immune receptors and methods of use thereof |
-
2020
- 2020-05-01 EP EP20726662.8A patent/EP3966242A1/en active Pending
- 2020-05-01 WO PCT/US2020/030968 patent/WO2020227071A1/en not_active Ceased
- 2020-05-01 JP JP2021564745A patent/JP2022532868A/ja active Pending
- 2020-05-01 US US16/864,478 patent/US11434297B2/en active Active
- 2020-05-01 CN CN202510986247.3A patent/CN121021694A/zh active Pending
- 2020-05-01 CA CA3139061A patent/CA3139061A1/en active Pending
- 2020-05-01 AU AU2020269268A patent/AU2020269268A1/en active Pending
- 2020-05-01 CN CN202080048186.1A patent/CN114040926B/zh active Active
-
2022
- 2022-08-01 US US17/816,540 patent/US11919963B2/en active Active
-
2024
- 2024-12-27 JP JP2024231707A patent/JP2025060941A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025060941A5 (enExample) | ||
| US20220380459A1 (en) | Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use | |
| JP7539840B2 (ja) | Ｃｄ３３を標的とする抗体可変ドメイン及びその使用 | |
| TWI867066B (zh) | 靶向flt3之抗體及其用途 | |
| US20220025037A1 (en) | Antibody variable domains targeting dll3, and use thereof | |
| JP2018519263A5 (enExample) | ||
| US20240228645A1 (en) | Antibodies targeting baff-r and use thereof | |
| CN111148761A (zh) | 多特异性抗体及其制备和使用方法 | |
| US20230220084A1 (en) | Antibodies Targeting CLEC12A and Use Thereof | |
| JP2023536627A (ja) | Ｅｇｆｒを標的とする抗体およびその使用 | |
| CN117321087A (zh) | 包含与细胞因子融合用于nk细胞衔接的nkp46结合位点、癌抗原结合位点的多特异性蛋白质 | |
| JP2024521405A (ja) | Ｎｋｐ４６、サイトカイン受容体、腫瘍抗原およびｃｄ１６ａに結合する多特異性タンパク質 | |
| CA3226688A1 (en) | Expansion of memory natural killer cells | |
| IL292430A (en) | Sequential anti-cd19 therapy | |
| Shearman et al. | Construction, expression, and biologic activity of murine/human chimeric antibodies with specificity for the human alpha/beta T cell receptor. | |
| EA049630B1 (ru) | Мультиспецифические связывающие белки, которые связывают cd33, nkg2d и cd16, и способы применения | |
| HK40018991A (en) | Multi-specific antibodies and methods of making and using thereof |